Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 5, 1998, Pages 633-638

  Katelaris, P H ^a,b   Nguyen, T V ^a   Robertson, G J ^a   Bradbury, R ^a   Ngu, M C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Helicobacter pylori; Metronidazole resistance; Prevalence

Indexed keywords

METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIUM IDENTIFICATION; DYSPEPSIA; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; STRAIN DIFFERENCE;

EID: 0032467280     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb00660.x     Document Type: Article

References (21)

1. Penston JG. Helicobacter pylori eradication-understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
2. Rautelin H, Seppala K, Renkonen O-V, Vaino U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
3. Misiewicz JJ, Harris AW, Bardhan KD et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 1997; 41: 735-9.
4. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2.
5. Forbes GM, Collins BJ, McCullough CA, Coombs GW, Robins PD. Short duration therapy for Helicobacter pylori in Western Australia: The impact of metronidazole resistance. Aust NZ J Med 1998; 28: 13-7.
6. Lind T, Megraud F, Bardhan KD et al. The MACH2 study: antimicrobial resistance in Helicobacter pylori therapy - the impact of omeprazole. Gut 1997; 41 (Suppl. 1): A89.
7. Glupczynski Y, Burette A, DeKoster E et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7.
8. Megraud F. H. pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (Eds.). Helicobacter pylori: Basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers, 1994: 570-830.
9. Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired metronidazole resistance to clarithromycin, metronidazole and amoxycillin - influence on treatment outcome. Am J Gastroenterol 1998; 93: 386-9.
10. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993; 32: 45-9.
11. Banatvala N GRD, Abdi Y, Clements L, Rampton DS, Hardie JM, Feldman RA. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 35: 1562-6.
12. McManus P, Leigh Hammond M, Whicker SD, Primrose JG, Mant A, Fairall SR. Antibiotic use in the Australian community, 1990-1995. Med J Aust 1997; 167: 124-7.
13. Drug Utilisation Sub-Committee database. Dept of Health and Family Services. Canberra ACT. Data on File.
14. Tytgat GNJ. Review article: treatment that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
15. Lerang F, Mourn B, Haug JB et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997; 92: 248-53.
16. Thijs JC, Van Zwet AA, Thijs WJ, Van der Wouden EJ, Kooy A. One week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance. Aliment Pharmacol Ther 1997; 11: 305-9.
17. Bell GD, Powell K, Burridge SM et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.
18. Veldhuyzen van Zanten S, Hunt RH, Cockeram A et al. Adding once-daily omeprazole 20 mg to metronidazole/ amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. Am J Gastroenterol 1998; 93: 5-10.
19. Jones BE, Weltman M, Liddle C. Eradication of Helicobacter pylori in consultant practice - a prospective study utilizing a carbon-14 urea breath test. J Gastroenterol Hepatol 1997; 12 (Suppl.): A53.
20. Van der Hulst RWM, van der Ende A, Homan A, Roorda P, Danken J, Tytgat GNJ. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998; 42: 166-9.
21. Xia HH-X, Kalantar J, Rose D, Talley NJ. Susceptibility testing of H. pylori to metronidazole and clarithromycin: is one isolate from a single site adequate? Gastroenterology 1997; 112 (Suppl.): A1122.